ClearPoint Neuro (CLPT) EBITDA Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 3,523.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,523.00 |
| Dec 31, 2025 | 1,870.00 |
| Sep 30, 2025 | 1,420.00 |
| Jun 30, 2025 | 1,921.00 |
| Mar 31, 2025 | 417.00 |
| Dec 31, 2024 | 2,047.00 |
| Sep 30, 2024 | 1,966.00 |
| Jun 30, 2024 | 3,971.00 |
| Mar 31, 2024 | -107.00 |
| Dec 31, 2023 | -815.00 |
| Sep 30, 2023 | -4,884.00 |
| Jun 30, 2023 | -6,032.00 |
| Mar 31, 2023 | -6,634.00 |
| Dec 31, 2022 | -10,527.00 |
| Sep 30, 2022 | -4,264.00 |
| Jun 30, 2022 | -3,123.00 |
| Mar 31, 2022 | -3,748.00 |
| Dec 31, 2021 | -4,999.00 |
| Sep 30, 2021 | -1,642.00 |
| Jun 30, 2021 | -46.00 |
| Mar 31, 2021 | 3,379.00 |
| Sep 30, 2019 | 7,466.00 |
| Jun 30, 2019 | 14,308.00 |
| Mar 31, 2019 | 10,223.00 |
| Sep 30, 2018 | 9,260.00 |
| Jun 30, 2018 | 907,219.00 |
| Mar 31, 2018 | 21,354.00 |
| Sep 30, 2016 | 645,291.00 |
| Jun 30, 2016 | 24,527.00 |
| Mar 31, 2016 | 74,644.00 |
| Sep 30, 2015 | -6,949.00 |
| Jun 30, 2015 | -883,482.00 |
| Mar 31, 2015 | 76,145.00 |
| Dec 31, 2014 | -690,076.00 |
| Sep 30, 2014 | -32,116.00 |
| Jun 30, 2014 | 182,773.00 |
| Mar 31, 2014 | 48,647.00 |